About the project
POINT develops knowledge-based biomarkers for prevention and management of non-communicable diseases (NCDs) associated with the post-acute phase of COVID-19 (occurring ≥4 months after the acute phase).
A virtual twin model will offer clinical decision support, and clinical guidelines and recommendations for the entire health care value chain with special attention to vulnerable groups.